New Jersey A 4184: Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.

Status: Introduced, Referred to Assembly Health Committee (as of 2026-02-19)

State: New Jersey · Session: 222 · Bill: A 4184

Sponsors: Murphy, Carol A.

View New Jersey A 4184 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.